Amplifon S.p.A. (AMFPF)
Amplifon S.p.A. operates in the Medical - Distribution industry of the Healthcare sector, headquartered in Milan, MI, IT. The stock last traded at $11.21, up 0.00% on the session, giving a market capitalisation of $2.97B. On trailing twelve-month figures it carries a trailing P/E of 42.03, a net margin of 3.0%. Its beta of 0.96 implies it has historically moved less than the broad market.
Amplifon SpA engages in the distribution, application, and customization of hearing solutions. It contributes to the development of detection and rehabilitation techniques in otology diagnosis, and management of computerized and integrated auditory systems. It operates through the following geographical segments: Europe, Middle East and Africa (EMEA), Americas, Asia-Pacific, and Corporate. The company was founded by Algernon Charles Holland in 1950 and is headquartered in Milan, Italy.
Amplifon S.p.A. is most often compared with the following Healthcare names: